$4.99 Billion is the total value of OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s 259 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
WLTW | WILLIS T | $75,800,000,000 | -0.4% | 500,000 | 0.0% | 1.52% | +3.6% | |
CTSH | COGNIZANcla | $39,495,000,000 | -1.9% | 500,000 | 0.0% | 0.79% | +2.1% | |
RAMBUS Inote1 | $18,180,000,000 | -6.8% | 17,000,000 | 0.0% | 0.36% | -3.2% | ||
AEGERIONnote2 | $15,406,000,000 | -11.6% | 22,000,000 | 0.0% | 0.31% | -8.0% | ||
TPGHU | TPG PACEunit9 | $8,726,000,000 | +0.6% | 831,000 | 0.0% | 0.18% | +4.8% | |
DISH NETnote3 | $4,825,000,000 | -2.5% | 5,000,000 | 0.0% | 0.10% | +2.1% | ||
LACQU | LEISUREunit9 | $4,220,000,000 | +1.4% | 420,365 | 0.0% | 0.08% | +6.2% | |
GOODRICHdebt1 | $4,200,000,000 | 0.0% | 4,000,000 | 0.0% | 0.08% | +3.7% | ||
HYG | ISHARESput | $1,042,000,000 | -6.1% | 1,500,000 | 0.0% | 0.02% | 0.0% | |
ELECTRONnote0 | $992,000,000 | +2.0% | 1,000,000 | 0.0% | 0.02% | +5.3% | ||
BIOMARINnote0 | $1,002,000,000 | +6.3% | 1,000,000 | 0.0% | 0.02% | +11.1% | ||
TWITTERnote0 | $970,000,000 | +1.3% | 1,000,000 | 0.0% | 0.02% | +5.6% | ||
FINISARnote0 | $909,000,000 | +0.9% | 1,000,000 | 0.0% | 0.02% | +5.9% | ||
NUANCE Cdbcv1 | $899,000,000 | -5.9% | 1,000,000 | 0.0% | 0.02% | 0.0% | ||
MACQUARInote2 | $890,000,000 | -0.2% | 1,000,000 | 0.0% | 0.02% | +5.9% | ||
ENSCO JEnote3 | $845,000,000 | +5.1% | 1,000,000 | 0.0% | 0.02% | +13.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
META PLATF | 36 | Q3 2023 | 2.3% |
SPDR S&P 5 | 33 | Q3 2023 | 0.7% |
ACTIVISION | 29 | Q3 2023 | 71.3% |
AMAZON COM | 29 | Q3 2023 | 0.8% |
GAMING & L | 29 | Q3 2023 | 0.8% |
SPDR S&P | 29 | Q1 2023 | 0.1% |
DISNEY W | 28 | Q3 2021 | 2.0% |
POST HLD | 27 | Q2 2020 | 1.8% |
GENERAL | 27 | Q3 2022 | 1.4% |
CAMDEN PPT | 27 | Q3 2023 | 0.6% |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
HERON THERAPEUTICS, INC. /DE/Sold out | February 13, 2023 | 0 | 0.0% |
MAGELLAN HEALTH INCSold out | February 13, 2023 | 0 | 0.0% |
New Providence Acquisition Corp. II | February 13, 2023 | 2,227,500 | 8.9% |
Nuance Communications, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
SCP & CO Healthcare Acquisition CoSold out | February 13, 2023 | 0 | 0.0% |
ACORDA THERAPEUTICS INCSold out | February 14, 2022 | 0 | 0.0% |
Amryt Pharma plc | February 14, 2022 | 9,950,000 | 3.1% |
Evolv Technologies Holdings, Inc. | February 14, 2022 | 1,547,311 | 1.1% |
GreenSky, Inc. | February 14, 2022 | 698,553 | 0.8% |
GTY Technology Holdings Inc. | February 14, 2022 | 758,000 | 1.3% |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-05-15 |
13F-HR/A | 2024-05-15 |
13F-HR/A | 2024-05-15 |
13F-HR/A | 2024-05-15 |
13F-HR | 2024-05-15 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR | 2024-02-14 |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.
Compare quarters
The following issues were detected while analyzing the report:
- The reported total value is incorrect (4992907000.0 != 4992907000000.0)
- The reported number of holdings is incorrect (259 != 261)
- The reported has been amended
Export OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s holdings